Lawrence Fong

33PUBLICATIONS
328CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

|Jan 20, 2026
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.

Tony Li, Arielle Ilano, Marcel Arias-Badia

|Oct 08, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.

Bridget P Keenan, Guilin Qiao, Nicholas Kunda

|Aug 07, 2025
CD4+ T cell dysfunction in cancer.

Hrishi Venkatesh, Lawrence Fong

|Apr 01, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response.

Miho Tanaka, Lotus Lum, Kenneth H Hu

Pageof 6

Frequent Collaborators

5 joint publications

Bridget P Keenan

4 joint publications

Marcel Arias-Badia

4 joint publications

Eliezer M Van Allen

3 joint publications

Serena S Kwek